Tissue chips help translate respiratory disease research into clinical applications

Scientists are developing advanced tools to understand and treat neurological symptoms such as brain fog associated with respiratory diseases like influenza.

The latest updates on cancer research from the weekend

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Hi, it’s Meghana. Lots

April 8, 2024

EC upgrades approval for J&J’s Rybrevant/chemotherapy combination in NSCLC – Pharmaceutical Technology

Rybrevant with chemotherapy is the first treatment to offer prolonged progression-free survival for EGFR-mutated non-small cell lung cancer (NSCLC) patients for whom prior therapy has

August 27, 2024

FDA Staff Highly Skeptical of Confirmatory Data on KRAS Inhibitor in NSCLC

Ahead of a meeting of the Oncologic Drugs Advisory Committee on Thursday, FDA reviewers raised a host of concerns about the confirmatory trial data for

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.